HUP0000523A2 - Éterlipid/kiegészítő alakú lipid kombinációt tartalmazó hordozók és terápiai alkalmazásuk - Google Patents

Éterlipid/kiegészítő alakú lipid kombinációt tartalmazó hordozók és terápiai alkalmazásuk

Info

Publication number
HUP0000523A2
HUP0000523A2 HU0000523A HUP0000523A HUP0000523A2 HU P0000523 A2 HUP0000523 A2 HU P0000523A2 HU 0000523 A HU0000523 A HU 0000523A HU P0000523 A HUP0000523 A HU P0000523A HU P0000523 A2 HUP0000523 A2 HU P0000523A2
Authority
HU
Hungary
Prior art keywords
entherlipid
therapeutic uses
carriers containing
lipid combination
shape lipid
Prior art date
Application number
HU0000523A
Other languages
English (en)
Inventor
J.Craig Franklin
Andrew S. Janoff
Eric Mayhew
Walter Perkins
Original Assignee
The Liposome Company, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Liposome Company, Inc. filed Critical The Liposome Company, Inc.
Publication of HUP0000523A2 publication Critical patent/HUP0000523A2/hu
Publication of HUP0000523A3 publication Critical patent/HUP0000523A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Abstract

A találmány általánős képletű glicerőlipidből, a képletben R1jelentése telített vagy telítetlen szénhidrőgénlánc és Z jelentéseőxigén- vagy kénatőm, és kiegészítő alakú lipidből álló hőrdőzóttartalmazó gyógyászati készítményekre, valamint a készítményekkülönböző rendellenességek, példáűl rák és gyűlladásős állapőtőkkezelésére való alkalmazására vőnatkőzik. ŕ
HU0000523A 1996-10-15 1997-10-15 Carriers containing an entherlipid/complementarily shape lipid combination and therapeutic uses thereof HUP0000523A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/720,997 US5932242A (en) 1996-10-15 1996-10-15 Ether lipid-containing pharmaceutical compositions and therapeutic uses thereof
PCT/US1997/018546 WO1998016200A1 (en) 1996-10-15 1997-10-15 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof

Publications (2)

Publication Number Publication Date
HUP0000523A2 true HUP0000523A2 (hu) 2000-09-28
HUP0000523A3 HUP0000523A3 (en) 2000-10-30

Family

ID=24896093

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000523A HUP0000523A3 (en) 1996-10-15 1997-10-15 Carriers containing an entherlipid/complementarily shape lipid combination and therapeutic uses thereof

Country Status (18)

Country Link
US (2) US5932242A (hu)
EP (1) EP0966266A4 (hu)
JP (1) JP2001502332A (hu)
KR (1) KR100512689B1 (hu)
CN (1) CN1088582C (hu)
AU (1) AU722092B2 (hu)
BR (1) BR9712329A (hu)
CA (1) CA2268841A1 (hu)
CZ (1) CZ131799A3 (hu)
HK (1) HK1024638A1 (hu)
HU (1) HUP0000523A3 (hu)
IL (1) IL129473A0 (hu)
NO (1) NO991770L (hu)
NZ (1) NZ335125A (hu)
PL (1) PL190711B1 (hu)
SK (1) SK283817B6 (hu)
TR (1) TR199900799T2 (hu)
WO (1) WO1998016200A1 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667053B1 (en) 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
DE19829448A1 (de) * 1998-07-01 2000-10-12 Medmark Pharma Gmbh 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholin (ET180CH3) zur Behandlung von humanen Mammakarzinomen
WO2004062586A2 (en) * 2003-01-09 2004-07-29 Zeneus Pharma Limited Antineoplastic ether lipid compounds
EP1587518A4 (en) * 2003-01-09 2008-08-20 Zeneus Pharma Ltd ANTINEOPLASTIC LIPIDIC ETHER COMPOUNDS HAVING MODIFICATIONS AT THE CARBON GROUP SN-3
WO2004065719A2 (en) * 2003-01-16 2004-08-05 Hunter Douglas Inc. Covering for architectural surfaces and method of forming and applying same
ATE433979T1 (de) 2004-04-02 2009-07-15 Osi Pharm Inc Mit einem 6,6-bicyclischen ring substituierte heterobicyclische proteinkinaseinhibitoren
US8828972B2 (en) 2004-10-19 2014-09-09 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Formulations containing alkylphosphocholines using novel negative charge carriers
JP5382974B2 (ja) * 2005-03-11 2014-01-08 太陽化学株式会社 化粧料用組成物及び化粧料
KR100829595B1 (ko) 2006-12-11 2008-05-14 한국화학연구원 당이 결합된 인지질로 수식된 리포솜 및 이의 제조방법
DK2536414T3 (en) 2010-02-18 2016-10-03 Inserm (Institut Nat De La Santé Et De La Rech Médicale) METHOD FOR PREVENTING cancer metastasis
CA3047023C (en) * 2016-12-14 2022-05-31 Beijing Showby Pharmaceutical Co., Ltd. Class of bifunctional compounds with quaternary ammonium salt structure

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
DE3239858A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue d-mannitderivate als ausgangsprodukte zur synthese von phospholipiden
US5169637A (en) * 1983-03-24 1992-12-08 The Liposome Company, Inc. Stable plurilamellar vesicles
US4983397A (en) * 1985-08-19 1991-01-08 Board Of Regents, University Of Texas System Pharmaceutical compositions consisting of acylated phospholipids
US5260284A (en) * 1987-02-17 1993-11-09 Board Of Regents, The University Of Texas System Methods employing unique mixtures of polar and neutral lipids and sterol for lung surfactant replacement therapy
US4965391A (en) * 1987-10-23 1990-10-23 The University Of Michigan Radioiodinated phospholipid ether analogues
US5077057A (en) * 1989-04-05 1991-12-31 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
DE4132345A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Ether-lysolecithine und alkylphosphocholine in liposomen
EP0785773B1 (en) * 1994-10-14 2001-01-03 The Liposome Company, Inc. Ether lipid liposomes and their therapeutic use

Also Published As

Publication number Publication date
CN1088582C (zh) 2002-08-07
CA2268841A1 (en) 1998-04-23
HK1024638A1 (en) 2000-10-20
HUP0000523A3 (en) 2000-10-30
AU722092B2 (en) 2000-07-20
PL190711B1 (pl) 2005-12-30
US5932242A (en) 1999-08-03
US6017557A (en) 2000-01-25
NO991770L (no) 1999-06-09
BR9712329A (pt) 1999-08-31
TR199900799T2 (xx) 1999-07-21
SK283817B6 (sk) 2004-02-03
NO991770D0 (no) 1999-04-14
PL332696A1 (en) 1999-09-27
KR100512689B1 (ko) 2005-09-07
CN1240348A (zh) 2000-01-05
AU4756797A (en) 1998-05-11
IL129473A0 (en) 2000-02-29
KR20000049128A (ko) 2000-07-25
JP2001502332A (ja) 2001-02-20
NZ335125A (en) 1999-11-29
EP0966266A4 (en) 2006-01-11
EP0966266A1 (en) 1999-12-29
SK49399A3 (en) 1999-11-08
WO1998016200A1 (en) 1998-04-23
CZ131799A3 (cs) 1999-08-11

Similar Documents

Publication Publication Date Title
HRP20030831B1 (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
CY1109981T1 (el) Αναλογα του gaba για την προληψη και αγωγη γαστρεντερικης βλαβης
CY1111504T1 (el) Αζαδικυκλοαλκανια ως ρυθμιστες του ccr5
KR900009079A (ko) 비스(3,5-디-tert-부틸-4-히드록시페닐티오)메탄 함유 콜레스테롤 저하제겸 아테롬성 동맥 경화증 치료제
CY1113355T1 (el) Χρηση θεραπειας νευροτοξινης για θεραπευτικη αγωγη ουρολογικων και σχετικων διαταραχων
ATE404667T1 (de) Chromatin-regulatorgene
IT1285770B1 (it) Composti corticoidei
HUP0000523A2 (hu) Éterlipid/kiegészítő alakú lipid kombinációt tartalmazó hordozók és terápiai alkalmazásuk
PT815087E (pt) Derivados de fenilo trissubstituidos
BR9912327A (pt) Inibidores da uroquinase
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
TR200800693T2 (tr) Miyelin kaybettiren hastalıkların ya da durumların tedavi yöntemi
HUP0303463A1 (hu) Dimer izoflavonok
IT1318667B1 (it) Medicamento antinfiammatorio.
CY1110043T1 (el) 2-αμινοβενζουλ παραγωγα
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
HK1083767A1 (en) Combined use of a fibrate and orlistat for the treatment of obesity
HUP0100048A2 (hu) Arilszubsztituált piperazinszármazékok, alkalmazásuk gyógyszerkészítmények előállítására és a vegyületeket tartalmazó gyógyszerkészítmények
SE9404525D0 (sv) New uses of indolo-(3,2-b)-quinoxalines
NO20005548D0 (no) Mykobakterieinhibitorer
PT869785E (pt) 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
BR0114856A (pt) Combinação compreendendo camptotecina e um derivado de estilbeno para o tratamento de câncer
BR0206918A (pt) Uso de iloperidona

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees
GB9A Succession in title

Owner name: CEPHALON LIMITED, GB

Free format text: FORMER OWNER(S): ELAN PHARMACEUTICALS, INC., US; MEDEUS PHARMA LIMITED, GB; THE LIPOSOME COMPANY, INC., US; ZENEUS PHARMA LIMITED, GB

HC9A Change of name, address

Owner name: CEPHALON LIMITED, GB

Free format text: FORMER OWNER(S): ELAN PHARMACEUTICALS, INC., US; MEDEUS PHARMA LIMITED, GB; THE LIPOSOME COMPANY, INC., US; ZENEUS PHARMA LIMITED, GB